Evidence map›Paper›PMID 23320570›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2013

Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency.

E De Franco, C Shaw-Smith, S E Flanagan, E L Edghill, J Wolf, V Otte, F Ebinger, P Varthakavi, T Vasanthi, S Edvardsson and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Widening the phenotypic spectrum caused by pathogenicBMJ open diabetes research & care · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Neonatal and early-onset diabetes in Ukraine: Atypical features and mortality.Diabetic medicine : a journal of the British Diabetic Association · 2023
    Article
  10. Review
  11. Article
  12. First Japanese Family WithJournal of the Endocrine Society · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Animal Models of Pancreas Development, Developmental Disorders, and Disease.Advances in experimental medicine and biology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

E De FrancoInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
C Shaw-Smith
S E Flanagan
E L Edghill
J Wolf
V Otte
F Ebinger
P Varthakavi
T Vasanthi
S Edvardsson
A T Hattersley
S Ellard
University of Exeter · GBBrüderkrankenhaus St. Josef Paderborn · DECentrallasarettet Växjö · SEKanchi Kamakoti CHILDS Trust Hospital · INTopiwala National Medical College & BYL Nair Charitable Hospital · IN

Funding

Wellcome Trust 098395
6 · The paper itself

Abstract

aimsRecessive PDX1 (IPF1) mutations are a rare cause of pancreatic agenesis, with three cases reported worldwide. A recent report described two cousins with a homozygous hypomorphic PDX1 mutation causing permanent neonatal diabetes with subclinical exocrine insufficiency. The aim of our study was to investigate the possibility of hypomorphic PDX1 mutations in a large cohort of patients with permanent neonatal diabetes and no reported pancreatic hypoplasia or exocrine insufficiency.

methodsPDX1 was sequenced in 103 probands with isolated permanent neonatal diabetes in whom ABCC8, KCNJ11 and INS mutations had been excluded.

resultsSequencing analysis identified biallelic PDX1 mutations in three of the 103 probands with permanent neonatal diabetes (2.9%). One proband and his affected brother were compound heterozygotes for a frameshift and a novel missense mutation (p.A34fsX191; c.98dupC and p.P87L; c.260C>T). The other two probands were homozygous for novel PDX1 missense mutations (p.A152G; c.455C>G and p.R176Q; c.527G>A). Both mutations affect highly conserved residues located within the homeobox domain. None of the four cases showed any evidence of exocrine pancreatic insufficiency, either clinically, or, where data were available, biochemically. In addition a heterozygous nonsense mutation (p.C18X; c.54C>A) was identified in a fourth case.

conclusionsThis study demonstrates that recessive PDX1 mutations are a rare but important cause of isolated permanent neonatal diabetes in patients without pancreatic hypoplasia/agenesis. Inclusion of the PDX1 gene in mutation screening for permanent neonatal diabetes is recommended as a genetic diagnosis reveals the mode of inheritance, allows accurate estimation of recurrence risks and confirms the requirement for insulin treatment.

Indexed as

Mutation, MissenseDiabetes Mellitus, Type 1Exocrine GlandsFemaleHomeodomain ProteinsHumansHypoglycemic AgentsInfantInfant, NewbornInfant, Newborn, DiseasesInsulinMalePancreasPancreatic DiseasesTrans-ActivatorsHomeodomain ProteinsHypoglycemic AgentsInsulinpancreatic and duodenal homeobox 1 proteinTrans-Activators

Identifiers

PMID23320570
PMCPMC3654556
OpenAlexW2035969699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.